This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
An ileostomy is a surgical procedure in which the ileum (a part of the small intestine) is brought through an opening in the abdominal wall, creating a stoma. The stoma is an opening where waste can be collected in an external pouch. Ileostomies are most commonly performed due to inflammatory bowel disease (IBD) or bowel cancer. Ileostomies can be temporary or permanent, depending on the underlying cause. In some cases, an ileostomy may be reversed after the underlying condition has been treated. The main purpose of an ileostomy is to bypass the large intestine and allow waste to be expelled without passing through the colon. This can help to reduce symptoms of IBD or other intestinal disorders. Additionally, an ileostomy may be used to rest the colon and allow it to heal in cases of injury or infection. Ileostomies can be managed through lifestyle changes and medical management. Diet modifications can help to reduce symptoms and reduce the risk of blockages. Additionally, medications can help to reduce inflammation, improve bowel function, and prevent infection. Patients with an ileostomy must wear an external pouch to collect waste, which must be emptied and changed regularly. The pouch should be emptied at least three times a day, and changed once every two to three days. Additionally, the area around the stoma should be kept clean and free from moisture to prevent skin irritation and infection. In conclusion, ileostomies can be a life-altering experience, but with proper medical management and lifestyle changes, most patients can lead a normal life.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States